Table 1.
General characteristics of included patients
| n (%) | Median IQR | |
|---|---|---|
| Male gender | 287 (77.2) | |
| Age (years) | 47.7 (42.1–54.5) | |
| CDC C3 | 91 (24.5) | |
| CD4+ cell count (cells/μL) | 602 (423.5–825) | |
| Undetectable log10 HIV-RNA | 334 (89.8) | |
| HCV-positive | 76 (20.4) | |
| First line treatment | 53 (14.2) | |
| Overall duration of ART (months) | 123 (55.2–173) | |
| Duration of current cART (months) | 19.2 (11.0–36.4) |
Abbreviations: CDC, Center for Disease Control and Prevention; IQR, interquartile range; ART, antiretroviral therapy; cART, combined antiretroviral therapy.